MACOM (MTSI) Q4 2026 Earnings Call Transcript

MACOM reported Q4 FY2026 revenue of $424.8 million, up 62.7% year over year, and adjusted EPS of $2.09; FY2026 revenue rose 37% to $1.3 billion and adjusted EPS increased 61% to $5.60. Management guided Q1 FY2027 revenue to $450 million–$460 million and expects FY2027 data-center growth to exceed FY2026’s 74%, while targeting more than 30% growth in industrial and defense. Telecom faces softness in PON and broadband, with Q1 revenue expected flat to slightly down; planned FY2027 CapEx is $100 million–$110 million.

Analysis

The key market mechanism is operating leverage: if backlog converts while new products and utilization support mix, earnings can outgrow revenue. But the margin step-up is partly utilization-driven, so it is vulnerable to a demand pause; planned capacity and R&D spending raise execution stakes before all the longer-dated opportunities contribute. The differentiated near-term question is not the size of the stated market opportunity, but whether MACOM can secure external wafer and back-end capacity and turn customer sampling into repeatable shipments without diluting margins.

Data-center growth expectations appear increasingly embedded in the narrative, making order conversion and quarterly growth cadence more important than headline bookings. NPO could broaden the addressable analog content, but architecture choices and customer awards remain uncertain; highly integrated alternatives, including those from Astera Labs (ALAB), are a competitive risk rather than a confirmed share loss. Defense demand and LEO programs diversify end markets, but the cited satellite award contribution is not expected until 2028. Telecom softness in PON and broadband is a near-term offset, not evidence that all telecom demand is weakening.

Over days, the results and outlook may support momentum, but valuation and positioning are unavailable, so chasing a gap is not justified. Over 1–3 months, watch backlog conversion, external supply availability, and Q1 execution. Over 6–18 months, capacity ramp, NPO wins, defense program production, and CHIPS funding are pivotal. Falsifiers include data-center growth materially below management’s trajectory, sequential margin deterioration beyond the indicated progression, or delayed capacity/customer ramps.

Key Decisions for Investors

• MTSI: Prefer a staged long on post-earnings consolidation rather than buying an opening spike; keep exposure modest until valuation, customer-award evidence, and supply commitments are verified. Reassess if data-center growth or backlog conversion disappoints, or margins contract as capacity is added.
• Track the next 1–3 months for Q1 revenue and gross-margin delivery, book-to-bill/backlog conversion, and evidence that external foundry and assembly capacity can support demand. A miss against guidance or worsening lead-time constraints would weaken the thesis.
• Treat NPO, CW lasers, and the LEO award as option value, not core near-term earnings support. Upgrade conviction only on named design wins, production schedules, and reliability qualification; delay or loss of these milestones would invalidate the longer-dated upside case.
• No MTSI–ALAB pair trade yet: the call identifies competition in adjacent optical analog products, but the available information does not establish relative valuation, exposure, or win rates. Monitor customer architecture selections and product-level design wins before expressing a relative position.